US Patent 11510981 Nanoparticle compositions and methods for immunotherapy
Patent 11510981 was granted and assigned to NexImmune on November, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11510981 Nanoparticle compositions and methods for immunotherapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
